pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Vaccine · news · pharmadog
← back to Vaccine
News · Vaccine
688
stories
28d
Opinion: How knocking on doors can help beat measles — again
stat
28d
A counterintuitive way to build trust in measles vaccines and public health
stat
29d
ESMO: After leak, Merck and Moderna post phase 3 cancer vaccine data early
fiercebiotech
29d
How voters feel about trans rights and abortion access will soon be put to the test
stat
29d
Lilly puts $1.1B on the line for Hong Kong biotech’s AI drug delivery platform
biospace
Oct 19, 26
Opinion: I was a Theranos whistleblower. In ‘You Can See Everything,’ Elizabeth Holmes is still lying
stat
Oct 19, 26
STAT+: China moves to restrict foreign biotech acquisitions
stat
Oct 19, 26
Two former Republican lawmakers say the GOP’s vaccine position is a liability
stat
Oct 19, 26
From strategy to scale: How Saudi Arabia is building a biotech ecosystem
biopharma dive
Oct 19, 26
STAT+: Gilead’s IBD drug eliminated symptoms for patients, mid-stage study finds
stat
Oct 19, 26
Opinion: Measles is back — and becoming a midterm liability for Republicans
stat
Oct 19, 26
STAT+: Does Isomorphic Labs have what it takes to revolutionize drugmaking?
stat
Oct 19, 26
Nouscom raises $135M in Series D for lead cancer vaccine
endpoints
Oct 19, 26
Merck/Moderna, Summit/Akeso and ADCs to headline ESMO 2026
biospace
Oct 16, 26
STAT+: Up and down the ladder: The latest comings and goings
stat
Oct 16, 26
STAT+: Pharmalittle: We’re reading about an HHS peptide push, Trump’s pharma stock holdings, and more
stat
Oct 16, 26
STAT+: RevMed’s pancreatic cancer drug nears European approval
stat
Oct 16, 26
This week in charts: Moderna’s massive stock run
biopharma dive
Oct 16, 26
What to read before you go see that new documentary on Elizabeth Holmes
stat
Oct 16, 26
Nouscom raises $135M for pivotal trial of cancer-preventing vaccine candidate
fiercebiotech
Oct 16, 26
Opinion: I thought I knew why patients stopped taking their medicine. I was wrong
stat
Oct 16, 26
Opinion: Is Milton Friedman to blame for America’s health care woes?
stat
Oct 16, 26
STAT+: Coerced sex or a jealous ex? Jury weighs dueling accounts of star scientist David Sabatini’s downfall
stat
Oct 15, 26
Merck and Moderna have ‘lot of exploring to do’ after initial cancer vaccine success
stat
Oct 15, 26
CDC page supporting Covid vaccines for pregnancy went dark
endpoints
Oct 15, 26
STAT+: Verastem’s KRAS inhibitor shows promise in pancreatic cancer
stat
Oct 15, 26
After a melanoma diagnosis, mRNA cancer vaccine delivered a patient hope — and a path forward
stat
Oct 15, 26
Osivax pivots to combo approach after flu jab fails in Phase 2b
endpoints
Oct 15, 26
Webinar: The China question: Can US biotechs lead as investment heads east?
biospace
Oct 15, 26
STAT+: Pharmalittle: We’re reading about former FDA head calling DOGE a ‘disaster,’ an AstraZeneca AI deal, and more
stat
← prev
page 5 of 23
next →